Larotrectinib Sulfate is an orally administered tropomyosin receptor kinase inhibitor with demonstrated antineoplastic activity. It is a drug for the treatment of cancer.Reference standards of Larotrectinib Sulfate API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Larotrectinib Sulfate
Catalogue No.:PA 65 05000
CAS :
Molecular Formula : C21H24F2N6O6S
Molecular Weight : 526.52
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....